Lee Jun H, Chang Kevin K, Yoon Changhwan, Tang Laura H, Strong Vivian E, Yoon Sam S
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.
Department of Surgery, Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea.
Ann Surg. 2018 Jan;267(1):105-113. doi: 10.1097/SLA.0000000000002040.
To examine sites of initial recurrence in patients after resection of gastric and gastroesophageal junction Siewert II/III adenocarcinoma (GA).
There are few recent studies on recurrence for Western patients following potentially curative resection of GA.
A review of a prospectively maintained, single institution database was performed. Clinicopathologic factors, site(s) of initial recurrence, disease-free survival, and overall survival were examined.
From January 2000 to June 2010, 957 patients underwent potentially curative resection for GA, 435 patients (46%) had recurrent disease, and complete data on recurrence site(s) could be obtained in 386 patients. Tumors were Lauren intestinal type in 206 (53%) and diffuse or mixed-type in 180 (47%). Median time to recurrence was 12 months and 75% of recurrences occurred within 2 years. There was a significant difference in pattern of initial recurrence between the intestinal and diffuse/mixed cohorts (P < 0.001). For intestinal tumors, distant metastasis was the most common site (54%), followed by locoregional (20%), peritoneal (15%), and multifocal (11%). For diffuse/mixed tumors, peritoneal recurrence was the most common (37%), followed by distant (32%), locoregional (22%), and multifocal (9%). On multivariate analysis, Lauren histologic type was the only significant factor that was associated with both peritoneal recurrence (diffuse, hazard ratio 2.22, confidence interval 1.38-3.94) and distant recurrence (intestinal, hazard ratio 1.888, confidence interval 1.202-2.966). After recurrence, median overall survival was only 8.4 months.
In GA patients who recur after resection, patterns of recurrence vary significantly based on Lauren histologic type.
研究胃及胃食管交界部Siewert II/III型腺癌(GA)切除术后患者的初始复发部位。
近期关于西方患者GA根治性切除术后复发情况的研究较少。
对前瞻性维护的单机构数据库进行回顾性分析。研究了临床病理因素、初始复发部位、无病生存期和总生存期。
2000年1月至2010年6月,957例患者接受了GA根治性切除术,435例(46%)出现疾病复发,386例患者可获得复发部位的完整数据。肿瘤为Lauren肠型的有206例(53%),弥漫型或混合型的有180例(47%)。复发的中位时间为12个月,75%的复发发生在2年内。肠型和弥漫/混合型队列的初始复发模式存在显著差异(P<0.001)。对于肠型肿瘤,远处转移是最常见的部位(54%),其次是局部区域(20%)、腹膜(15%)和多灶性(11%)。对于弥漫/混合型肿瘤,腹膜复发是最常见的(37%),其次是远处(32%)、局部区域(22%)和多灶性(9%)。多因素分析显示,Lauren组织学类型是与腹膜复发(弥漫型,风险比2.22,置信区间1.38-3.94)和远处复发(肠型,风险比1.888,置信区间1.202-2.966)均相关的唯一显著因素。复发后,总生存期的中位时间仅为8.4个月。
在GA切除术后复发的患者中,复发模式因Lauren组织学类型而异。